AHFS December 2025 Update

This update contains 5 new monographs and 41 revised monographs.

New monographs: Donidalorsen Sodium; Elamipretide Hydrochloride;
Imlunestrant Tosylate; Paltusotine Hydrochloride; Remibrutinib.

Revised monographs: amLODIPine; Antihemophilic Factor (Recombinant), Fc-
VWF-XTEN Fusion Protein-ehtl; Azilsartan Kamedoxomil; Benznidazole;
Cabozantinib S-malate; Capsaicin; Cefuroxime; Ciltacabtagene Autoleucel;
COVID-19 Vaccine, Adjuvanted (Novavax) (2025-2026 Formula); COVID-19
Vaccine, mRNA (Moderna) (2025-2026); COVID-19 Vaccine, mRNA (Pfizer-
BioNTech) (2025-2026 Formula); Darunavir; Dexmethylphenidate and
Serdexmethylphenidate; Diazoxide Choline; Diclofenac; Digoxin; Eltrombopag;
Eptifibatide; Ergoloid Mesylates; Garadacimab-gxii; Glofitamab-gxbm; Insulin
Degludec; Insulin Human; Irbesartan; Linagliptin; Lisinopril; Losartan Potassium;
metFORMIN Hydrochloride; migALAstat Hydrochloride; Netupitant/Palonosetron
Hydrochloride, Fosnetupitant/Palonosetron Hydrochloride; Nifurtimox; Nitisinone;
Nitric Oxide; Olmesartan Medoxomil; Palivizumab; Sacubitril and Valsartan;
sAXagliptin; Tirofiban Hydrochloride; Tivozanib Hydrochloride; Tranexamic Acid;
Vandetanib.